vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and Life360, Inc. (LIF). Click either name above to swap in a different company.
Life360, Inc. is the larger business by last-quarter revenue ($146.0M vs $85.1M, roughly 1.7× 4D Molecular Therapeutics, Inc.). Life360, Inc. runs the higher net margin — 88.8% vs 22.8%, a 66.0% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 26.4%). Life360, Inc. produced more free cash flow last quarter ($36.6M vs $28.5M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 36.6%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Life360, Inc. develops family-focused safety and connectivity platforms. Core offerings include real-time location sharing, emergency alerts, driving behavior analysis tools and identity theft protection. It serves consumer markets across North America, Europe and Asia-Pacific, with most revenue from tiered premium subscription plans.
FDMT vs LIF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $146.0M |
| Net Profit | $19.4M | $129.7M |
| Gross Margin | — | 75.1% |
| Operating Margin | 17.3% | 6.1% |
| Net Margin | 22.8% | 88.8% |
| Revenue YoY | 8508900.0% | 26.4% |
| Net Profit YoY | 139.1% | 1425.9% |
| EPS (diluted) | $0.43 | $1.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $146.0M | ||
| Q3 25 | $90.0K | $124.5M | ||
| Q2 25 | $15.0K | $115.4M | ||
| Q1 25 | $14.0K | $103.6M | ||
| Q4 24 | $1.0K | $115.5M | ||
| Q3 24 | $3.0K | $92.9M | ||
| Q2 24 | $5.0K | $84.9M | ||
| Q1 24 | $28.0K | $78.2M |
| Q4 25 | $19.4M | $129.7M | ||
| Q3 25 | $-56.9M | $9.8M | ||
| Q2 25 | $-54.7M | $7.0M | ||
| Q1 25 | $-48.0M | $4.4M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | $-43.8M | $7.7M | ||
| Q2 24 | $-35.0M | $-11.0M | ||
| Q1 24 | $-32.4M | $-9.8M |
| Q4 25 | — | 75.1% | ||
| Q3 25 | — | 78.0% | ||
| Q2 25 | — | 78.4% | ||
| Q1 25 | — | 80.6% | ||
| Q4 24 | — | 74.0% | ||
| Q3 24 | — | 75.4% | ||
| Q2 24 | — | 75.0% | ||
| Q1 24 | — | 76.7% |
| Q4 25 | 17.3% | 6.1% | ||
| Q3 25 | -67983.3% | 4.6% | ||
| Q2 25 | -396373.3% | 1.7% | ||
| Q1 25 | -383007.1% | 2.1% | ||
| Q4 24 | — | 4.9% | ||
| Q3 24 | -1704400.0% | -5.3% | ||
| Q2 24 | -849120.0% | -2.8% | ||
| Q1 24 | -136200.0% | -8.2% |
| Q4 25 | 22.8% | 88.8% | ||
| Q3 25 | -63195.6% | 7.9% | ||
| Q2 25 | -364386.7% | 6.1% | ||
| Q1 25 | -342657.1% | 4.2% | ||
| Q4 24 | — | 7.4% | ||
| Q3 24 | -1461433.3% | 8.3% | ||
| Q2 24 | -699060.0% | -12.9% | ||
| Q1 24 | -115717.9% | -12.5% |
| Q4 25 | $0.43 | $1.53 | ||
| Q3 25 | $-1.01 | $0.11 | ||
| Q2 25 | $-0.98 | $0.08 | ||
| Q1 25 | $-0.86 | $0.05 | ||
| Q4 24 | — | $0.14 | ||
| Q3 24 | $-0.79 | $0.09 | ||
| Q2 24 | $-0.63 | $-0.15 | ||
| Q1 24 | $-0.66 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $494.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $548.2M |
| Total Assets | $566.7M | $959.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $494.3M | ||
| Q3 25 | $305.1M | $455.7M | ||
| Q2 25 | $293.2M | $432.7M | ||
| Q1 25 | $321.4M | $168.9M | ||
| Q4 24 | $424.9M | $159.2M | ||
| Q3 24 | $501.9M | $159.0M | ||
| Q2 24 | $541.9M | $160.8M | ||
| Q1 24 | $525.9M | $73.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $5.2M |
| Q4 25 | $505.7M | $548.2M | ||
| Q3 25 | $369.0M | $391.4M | ||
| Q2 25 | $420.9M | $366.7M | ||
| Q1 25 | $469.7M | $376.3M | ||
| Q4 24 | $510.6M | $358.5M | ||
| Q3 24 | $552.9M | $339.7M | ||
| Q2 24 | $588.3M | $326.7M | ||
| Q1 24 | $600.6M | $239.8M |
| Q4 25 | $566.7M | $959.7M | ||
| Q3 25 | $424.0M | $787.5M | ||
| Q2 25 | $473.6M | $753.6M | ||
| Q1 25 | $515.7M | $455.4M | ||
| Q4 24 | $560.4M | $441.6M | ||
| Q3 24 | $604.0M | $427.4M | ||
| Q2 24 | $620.1M | $405.9M | ||
| Q1 24 | $629.9M | $318.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $36.8M |
| Free Cash FlowOCF − Capex | $28.5M | $36.6M |
| FCF MarginFCF / Revenue | 33.5% | 25.1% |
| Capex IntensityCapex / Revenue | 0.1% | 0.2% |
| Cash ConversionOCF / Net Profit | 1.47× | 0.28× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $86.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $36.8M | ||
| Q3 25 | $-46.5M | $26.4M | ||
| Q2 25 | $-43.4M | $13.3M | ||
| Q1 25 | $-47.8M | $12.1M | ||
| Q4 24 | $-134.6M | $12.3M | ||
| Q3 24 | $-29.4M | $6.3M | ||
| Q2 24 | $-30.2M | $3.3M | ||
| Q1 24 | $-29.1M | $10.7M |
| Q4 25 | $28.5M | $36.6M | ||
| Q3 25 | $-46.6M | $25.6M | ||
| Q2 25 | $-43.4M | $12.7M | ||
| Q1 25 | $-48.4M | $11.9M | ||
| Q4 24 | $-138.4M | $11.2M | ||
| Q3 24 | $-31.2M | $6.3M | ||
| Q2 24 | $-30.6M | $3.2M | ||
| Q1 24 | $-29.8M | — |
| Q4 25 | 33.5% | 25.1% | ||
| Q3 25 | -51765.6% | 20.6% | ||
| Q2 25 | -289620.0% | 11.0% | ||
| Q1 25 | -345635.7% | 11.5% | ||
| Q4 24 | -13837100.0% | 9.7% | ||
| Q3 24 | -1038966.7% | 6.8% | ||
| Q2 24 | -611840.0% | 3.8% | ||
| Q1 24 | -106421.4% | — |
| Q4 25 | 0.1% | 0.2% | ||
| Q3 25 | 101.1% | 0.6% | ||
| Q2 25 | 440.0% | 0.6% | ||
| Q1 25 | 4507.1% | 0.1% | ||
| Q4 24 | 378600.0% | 1.0% | ||
| Q3 24 | 59266.7% | 0.0% | ||
| Q2 24 | 6980.0% | 0.1% | ||
| Q1 24 | 2535.7% | 0.0% |
| Q4 25 | 1.47× | 0.28× | ||
| Q3 25 | — | 2.70× | ||
| Q2 25 | — | 1.90× | ||
| Q1 25 | — | 2.75× | ||
| Q4 24 | — | 1.45× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
